Lexicon Pharmaceuticals

Results: 10



#Item
1CORPORATE GOVERNANCE GUIDELINES The Board of Directors (the “Board”) of Lexicon Pharmaceuticals, Inc. (“Lexicon” or the “Corporation”) has adopted these guidelines to promote the effective functioning of the

CORPORATE GOVERNANCE GUIDELINES The Board of Directors (the “Board”) of Lexicon Pharmaceuticals, Inc. (“Lexicon” or the “Corporation”) has adopted these guidelines to promote the effective functioning of the

Add to Reading List

Source URL: www.lexpharma.com

Language: English - Date: 2016-11-24 20:46:37
    2TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc

    TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc

    Add to Reading List

    Source URL: www.regeneron.com

    Language: English - Date: 2015-04-07 14:06:33
    3TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc

    TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc

    Add to Reading List

    Source URL: www.regeneron.com

    Language: English - Date: 2015-04-07 14:06:33
    4For Immediate Release  Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A

    For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A

    Add to Reading List

    Source URL: www.astellas.com

    Language: English - Date: 2010-06-27 23:10:21
    5Microsoft Word - Tioga Feb 2010 Financing PR FINAL

    Microsoft Word - Tioga Feb 2010 Financing PR FINAL

    Add to Reading List

    Source URL: www.forwardventures.com

    Language: English - Date: 2011-08-15 11:58:26
    6Microsoft Word - ENMD Fact Sheet - draft 12 FINAL FOR JH PRINTING.docx

    Microsoft Word - ENMD Fact Sheet - draft 12 FINAL FOR JH PRINTING.docx

    Add to Reading List

    Source URL: www.entremed.com

    Language: English - Date: 2014-01-13 07:02:20
    7Corporate Introduction (NASDAQ: ENMD) January[removed]

    Corporate Introduction (NASDAQ: ENMD) January[removed]

    Add to Reading List

    Source URL: www.entremed.com

    Language: English - Date: 2014-02-11 11:41:01
    8

    PDF Document

    Add to Reading List

    Source URL: www.lexicon-genetics.com

    Language: English - Date: 2012-06-20 17:47:40
    9

    PDF Document

    Add to Reading List

    Source URL: www.lexicon-genetics.com

    Language: English - Date: 2012-06-20 17:47:47
    10

    PDF Document

    Add to Reading List

    Source URL: www.lexicon-genetics.com

    Language: English - Date: 2012-06-20 17:47:48